In addition, even higher urine Wnt5A concentration was determined in AD SLE patients (5.17 ± 0.54 ng/mL) compared with LDA SLE patients (2.27 ± 0.06 ng/mL) (p < 0.0001) (Fig. 2B). The gene discussed is WNT5A; the disease is Alzheimer disease.